The Korean clinical research center for end- stage renal disease study validates the association of hemoglobin and erythropoiesis-stimulating agent dose with mortality in hemodialysis patients
Clinical Research Center for End-Stage Renal Disease (CRC- ESRD) Investigators
Research output: Contribution to journal › Article › peer-review
12Scopus
citations
Fingerprint
Dive into the research topics of 'The Korean clinical research center for end- stage renal disease study validates the association of hemoglobin and erythropoiesis-stimulating agent dose with mortality in hemodialysis patients'. Together they form a unique fingerprint.